18 and older, any sex, with Ketosis or Blood Glucose. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Blood Beta-hydroxybutyratePrimary· 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)
Are under the curve (AUC) across 240 minutes after supplement consumption (assessed at baseline and 15, 30, 60, 90, 120, 180, and 240 post-supplementation)
Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, there are different types of ketone supplements that differ in how they are metabolized in the body. Little is known about how these supplements affect blood ketone and blood glucose levels. The main objective of this study is to determine the effect of three different ketone supplements on blood ketones and blood glucose. The results of this pilot study will be used to guide future research for larger and more extensive studies on ketone supplements.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other trials of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester
Trials testing the same drug.
NCT05699707 — Metabolomic Signature of Exogenous Ketosis
· NA
· completed
Other recruiting trials for Ketosis
Currently open trials in the same condition.
NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism
· Phase 2, PHASE3
· recruiting
NCT06338969 — The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis
· NA
· recruiting
NCT05924295 — Variations in Ketone Metabolism
· NA
· recruiting
Other University of British Columbia trials
Trials by the same sponsor.
NCT07340970 — Sensory Stimuli During Cesarean Delivery
· not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases
· NA
· not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children
· NA
· not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI
· NA
· recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 1 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05273411.